nodes	percent_of_prediction	percent_of_DWPC	metapath
Dolasetron—CYP2C9—Gefitinib—lung cancer	0.0598	0.0973	CbGbCtD
Dolasetron—CYP2C9—Teniposide—lung cancer	0.058	0.0943	CbGbCtD
Dolasetron—CYP2D6—Gefitinib—lung cancer	0.0547	0.0889	CbGbCtD
Dolasetron—CYP2D6—Vinorelbine—lung cancer	0.0421	0.0685	CbGbCtD
Dolasetron—CYP3A4—Topotecan—lung cancer	0.038	0.0618	CbGbCtD
Dolasetron—CYP3A4—Gefitinib—lung cancer	0.0348	0.0565	CbGbCtD
Dolasetron—CYP3A4—Teniposide—lung cancer	0.0337	0.0548	CbGbCtD
Dolasetron—CYP2C9—Paclitaxel—lung cancer	0.0324	0.0526	CbGbCtD
Dolasetron—CYP2D6—Erlotinib—lung cancer	0.0323	0.0526	CbGbCtD
Dolasetron—CYP3A4—Vinorelbine—lung cancer	0.0268	0.0436	CbGbCtD
Dolasetron—CYP2C9—Cisplatin—lung cancer	0.026	0.0423	CbGbCtD
Dolasetron—CYP2D6—Vinblastine—lung cancer	0.026	0.0422	CbGbCtD
Dolasetron—CYP3A4—Crizotinib—lung cancer	0.0213	0.0347	CbGbCtD
Dolasetron—CYP3A4—Erlotinib—lung cancer	0.0206	0.0334	CbGbCtD
Dolasetron—CYP3A4—Paclitaxel—lung cancer	0.0188	0.0306	CbGbCtD
Dolasetron—CYP3A4—Irinotecan—lung cancer	0.0186	0.0302	CbGbCtD
Dolasetron—CYP3A4—Vinblastine—lung cancer	0.0165	0.0268	CbGbCtD
Dolasetron—CYP2D6—Doxorubicin—lung cancer	0.0159	0.0259	CbGbCtD
Dolasetron—CYP3A4—Etoposide—lung cancer	0.0149	0.0242	CbGbCtD
Dolasetron—CYP3A4—Docetaxel—lung cancer	0.0136	0.0221	CbGbCtD
Dolasetron—CYP3A4—Doxorubicin—lung cancer	0.0101	0.0165	CbGbCtD
Dolasetron—Dysgeusia—Docetaxel—lung cancer	0.000189	0.000608	CcSEcCtD
Dolasetron—Musculoskeletal discomfort—Cisplatin—lung cancer	0.000189	0.000606	CcSEcCtD
Dolasetron—Ataxia—Doxorubicin—lung cancer	0.000188	0.000605	CcSEcCtD
Dolasetron—Feeling abnormal—Irinotecan—lung cancer	0.000188	0.000604	CcSEcCtD
Dolasetron—Confusional state—Paclitaxel—lung cancer	0.000188	0.000603	CcSEcCtD
Dolasetron—Dysuria—Methotrexate—lung cancer	0.000187	0.0006	CcSEcCtD
Dolasetron—Gastrointestinal pain—Irinotecan—lung cancer	0.000187	0.000599	CcSEcCtD
Dolasetron—Dehydration—Doxorubicin—lung cancer	0.000186	0.000598	CcSEcCtD
Dolasetron—Anaphylactic shock—Paclitaxel—lung cancer	0.000186	0.000598	CcSEcCtD
Dolasetron—Oedema—Paclitaxel—lung cancer	0.000186	0.000598	CcSEcCtD
Dolasetron—Paraesthesia—Cisplatin—lung cancer	0.000186	0.000597	CcSEcCtD
Dolasetron—Thrombocytopenia—Etoposide—lung cancer	0.000186	0.000597	CcSEcCtD
Dolasetron—Tachycardia—Etoposide—lung cancer	0.000185	0.000595	CcSEcCtD
Dolasetron—Dyspnoea—Cisplatin—lung cancer	0.000185	0.000593	CcSEcCtD
Dolasetron—Hyperhidrosis—Etoposide—lung cancer	0.000184	0.000589	CcSEcCtD
Dolasetron—Feeling abnormal—Gemcitabine—lung cancer	0.000183	0.000588	CcSEcCtD
Dolasetron—Shock—Paclitaxel—lung cancer	0.000183	0.000588	CcSEcCtD
Dolasetron—Dizziness—Vinorelbine—lung cancer	0.000183	0.000588	CcSEcCtD
Dolasetron—Orthostatic hypotension—Doxorubicin—lung cancer	0.000183	0.000587	CcSEcCtD
Dolasetron—Thrombocytopenia—Paclitaxel—lung cancer	0.000182	0.000585	CcSEcCtD
Dolasetron—Tachycardia—Paclitaxel—lung cancer	0.000182	0.000583	CcSEcCtD
Dolasetron—Anorexia—Etoposide—lung cancer	0.000181	0.000581	CcSEcCtD
Dolasetron—Abdominal pain—Irinotecan—lung cancer	0.00018	0.000579	CcSEcCtD
Dolasetron—Body temperature increased—Irinotecan—lung cancer	0.00018	0.000579	CcSEcCtD
Dolasetron—Aspartate aminotransferase increased—Doxorubicin—lung cancer	0.00018	0.000579	CcSEcCtD
Dolasetron—Decreased appetite—Cisplatin—lung cancer	0.00018	0.000578	CcSEcCtD
Dolasetron—Hyperhidrosis—Paclitaxel—lung cancer	0.00018	0.000578	CcSEcCtD
Dolasetron—Pneumonia—Methotrexate—lung cancer	0.000179	0.000576	CcSEcCtD
Dolasetron—Anaemia—Docetaxel—lung cancer	0.000179	0.000574	CcSEcCtD
Dolasetron—Drowsiness—Methotrexate—lung cancer	0.000178	0.000572	CcSEcCtD
Dolasetron—Anorexia—Paclitaxel—lung cancer	0.000177	0.00057	CcSEcCtD
Dolasetron—Hypotension—Etoposide—lung cancer	0.000177	0.00057	CcSEcCtD
Dolasetron—Pain—Cisplatin—lung cancer	0.000177	0.000569	CcSEcCtD
Dolasetron—Alanine aminotransferase increased—Doxorubicin—lung cancer	0.000177	0.000567	CcSEcCtD
Dolasetron—Body temperature increased—Gemcitabine—lung cancer	0.000176	0.000564	CcSEcCtD
Dolasetron—Rash—Vinorelbine—lung cancer	0.000175	0.00056	CcSEcCtD
Dolasetron—Dermatitis—Vinorelbine—lung cancer	0.000174	0.00056	CcSEcCtD
Dolasetron—Abdominal distension—Doxorubicin—lung cancer	0.000174	0.00056	CcSEcCtD
Dolasetron—Hypotension—Paclitaxel—lung cancer	0.000174	0.000558	CcSEcCtD
Dolasetron—Stomatitis—Methotrexate—lung cancer	0.000174	0.000558	CcSEcCtD
Dolasetron—Headache—Vinorelbine—lung cancer	0.000173	0.000557	CcSEcCtD
Dolasetron—Syncope—Docetaxel—lung cancer	0.000173	0.000557	CcSEcCtD
Dolasetron—Palpitations—Docetaxel—lung cancer	0.000171	0.000548	CcSEcCtD
Dolasetron—Feeling abnormal—Cisplatin—lung cancer	0.000171	0.000548	CcSEcCtD
Dolasetron—Paraesthesia—Etoposide—lung cancer	0.00017	0.000547	CcSEcCtD
Dolasetron—Haematuria—Methotrexate—lung cancer	0.00017	0.000546	CcSEcCtD
Dolasetron—Loss of consciousness—Docetaxel—lung cancer	0.00017	0.000545	CcSEcCtD
Dolasetron—Pancreatitis—Doxorubicin—lung cancer	0.00017	0.000545	CcSEcCtD
Dolasetron—Musculoskeletal discomfort—Paclitaxel—lung cancer	0.00017	0.000544	CcSEcCtD
Dolasetron—Dyspnoea—Etoposide—lung cancer	0.000169	0.000543	CcSEcCtD
Dolasetron—Somnolence—Etoposide—lung cancer	0.000169	0.000542	CcSEcCtD
Dolasetron—Cough—Docetaxel—lung cancer	0.000169	0.000542	CcSEcCtD
Dolasetron—Epistaxis—Methotrexate—lung cancer	0.000168	0.00054	CcSEcCtD
Dolasetron—Hypersensitivity—Irinotecan—lung cancer	0.000168	0.00054	CcSEcCtD
Dolasetron—Convulsion—Docetaxel—lung cancer	0.000168	0.000538	CcSEcCtD
Dolasetron—Paraesthesia—Paclitaxel—lung cancer	0.000167	0.000537	CcSEcCtD
Dolasetron—Hypertension—Docetaxel—lung cancer	0.000167	0.000536	CcSEcCtD
Dolasetron—Dyspnoea—Paclitaxel—lung cancer	0.000166	0.000533	CcSEcCtD
Dolasetron—Somnolence—Paclitaxel—lung cancer	0.000165	0.000531	CcSEcCtD
Dolasetron—Decreased appetite—Etoposide—lung cancer	0.000165	0.00053	CcSEcCtD
Dolasetron—Chest pain—Docetaxel—lung cancer	0.000165	0.000528	CcSEcCtD
Dolasetron—Arthralgia—Docetaxel—lung cancer	0.000165	0.000528	CcSEcCtD
Dolasetron—Myalgia—Docetaxel—lung cancer	0.000165	0.000528	CcSEcCtD
Dolasetron—Dyspepsia—Paclitaxel—lung cancer	0.000164	0.000526	CcSEcCtD
Dolasetron—Body temperature increased—Cisplatin—lung cancer	0.000164	0.000526	CcSEcCtD
Dolasetron—Asthenia—Irinotecan—lung cancer	0.000164	0.000526	CcSEcCtD
Dolasetron—Fatigue—Etoposide—lung cancer	0.000164	0.000525	CcSEcCtD
Dolasetron—Pain—Etoposide—lung cancer	0.000162	0.000521	CcSEcCtD
Dolasetron—Constipation—Etoposide—lung cancer	0.000162	0.000521	CcSEcCtD
Dolasetron—Dysuria—Doxorubicin—lung cancer	0.000162	0.00052	CcSEcCtD
Dolasetron—Decreased appetite—Paclitaxel—lung cancer	0.000162	0.000519	CcSEcCtD
Dolasetron—Dry mouth—Docetaxel—lung cancer	0.000161	0.000517	CcSEcCtD
Dolasetron—Fatigue—Paclitaxel—lung cancer	0.00016	0.000515	CcSEcCtD
Dolasetron—Asthenia—Gemcitabine—lung cancer	0.00016	0.000512	CcSEcCtD
Dolasetron—Pain—Paclitaxel—lung cancer	0.000159	0.000511	CcSEcCtD
Dolasetron—Constipation—Paclitaxel—lung cancer	0.000159	0.000511	CcSEcCtD
Dolasetron—Confusional state—Docetaxel—lung cancer	0.000159	0.000511	CcSEcCtD
Dolasetron—Anaphylactic shock—Docetaxel—lung cancer	0.000158	0.000507	CcSEcCtD
Dolasetron—Oedema—Docetaxel—lung cancer	0.000158	0.000507	CcSEcCtD
Dolasetron—Pruritus—Gemcitabine—lung cancer	0.000157	0.000505	CcSEcCtD
Dolasetron—Feeling abnormal—Etoposide—lung cancer	0.000156	0.000502	CcSEcCtD
Dolasetron—Diarrhoea—Irinotecan—lung cancer	0.000156	0.000501	CcSEcCtD
Dolasetron—Pneumonia—Doxorubicin—lung cancer	0.000155	0.000499	CcSEcCtD
Dolasetron—Gastrointestinal pain—Etoposide—lung cancer	0.000155	0.000498	CcSEcCtD
Dolasetron—Shock—Docetaxel—lung cancer	0.000155	0.000498	CcSEcCtD
Dolasetron—Thrombocytopenia—Docetaxel—lung cancer	0.000154	0.000496	CcSEcCtD
Dolasetron—Drowsiness—Doxorubicin—lung cancer	0.000154	0.000496	CcSEcCtD
Dolasetron—Visual impairment—Methotrexate—lung cancer	0.000154	0.000495	CcSEcCtD
Dolasetron—Tachycardia—Docetaxel—lung cancer	0.000154	0.000494	CcSEcCtD
Dolasetron—Feeling abnormal—Paclitaxel—lung cancer	0.000153	0.000492	CcSEcCtD
Dolasetron—Hypersensitivity—Cisplatin—lung cancer	0.000153	0.00049	CcSEcCtD
Dolasetron—Gastrointestinal pain—Paclitaxel—lung cancer	0.000152	0.000489	CcSEcCtD
Dolasetron—Diarrhoea—Gemcitabine—lung cancer	0.000152	0.000488	CcSEcCtD
Dolasetron—Dizziness—Irinotecan—lung cancer	0.000151	0.000485	CcSEcCtD
Dolasetron—Urticaria—Etoposide—lung cancer	0.000151	0.000484	CcSEcCtD
Dolasetron—Jaundice—Doxorubicin—lung cancer	0.000151	0.000483	CcSEcCtD
Dolasetron—Stomatitis—Doxorubicin—lung cancer	0.000151	0.000483	CcSEcCtD
Dolasetron—Anorexia—Docetaxel—lung cancer	0.00015	0.000483	CcSEcCtD
Dolasetron—Body temperature increased—Etoposide—lung cancer	0.00015	0.000482	CcSEcCtD
Dolasetron—Abdominal pain—Etoposide—lung cancer	0.00015	0.000482	CcSEcCtD
Dolasetron—Tinnitus—Methotrexate—lung cancer	0.000149	0.000479	CcSEcCtD
Dolasetron—Asthenia—Cisplatin—lung cancer	0.000149	0.000477	CcSEcCtD
Dolasetron—Urticaria—Paclitaxel—lung cancer	0.000148	0.000475	CcSEcCtD
Dolasetron—Hypotension—Docetaxel—lung cancer	0.000147	0.000473	CcSEcCtD
Dolasetron—Haematuria—Doxorubicin—lung cancer	0.000147	0.000473	CcSEcCtD
Dolasetron—Body temperature increased—Paclitaxel—lung cancer	0.000147	0.000472	CcSEcCtD
Dolasetron—Abdominal pain—Paclitaxel—lung cancer	0.000147	0.000472	CcSEcCtD
Dolasetron—Epistaxis—Doxorubicin—lung cancer	0.000146	0.000468	CcSEcCtD
Dolasetron—Rash—Irinotecan—lung cancer	0.000144	0.000462	CcSEcCtD
Dolasetron—Dermatitis—Irinotecan—lung cancer	0.000144	0.000462	CcSEcCtD
Dolasetron—Musculoskeletal discomfort—Docetaxel—lung cancer	0.000144	0.000461	CcSEcCtD
Dolasetron—Chills—Methotrexate—lung cancer	0.000144	0.000461	CcSEcCtD
Dolasetron—Headache—Irinotecan—lung cancer	0.000143	0.000459	CcSEcCtD
Dolasetron—Diarrhoea—Cisplatin—lung cancer	0.000142	0.000455	CcSEcCtD
Dolasetron—Paraesthesia—Docetaxel—lung cancer	0.000142	0.000455	CcSEcCtD
Dolasetron—Bradycardia—Doxorubicin—lung cancer	0.000141	0.000453	CcSEcCtD
Dolasetron—Dyspnoea—Docetaxel—lung cancer	0.000141	0.000452	CcSEcCtD
Dolasetron—Somnolence—Docetaxel—lung cancer	0.00014	0.00045	CcSEcCtD
Dolasetron—Rash—Gemcitabine—lung cancer	0.00014	0.00045	CcSEcCtD
Dolasetron—Dermatitis—Gemcitabine—lung cancer	0.00014	0.00045	CcSEcCtD
Dolasetron—Hypersensitivity—Etoposide—lung cancer	0.00014	0.000449	CcSEcCtD
Dolasetron—Headache—Gemcitabine—lung cancer	0.000139	0.000447	CcSEcCtD
Dolasetron—Dyspepsia—Docetaxel—lung cancer	0.000139	0.000446	CcSEcCtD
Dolasetron—Decreased appetite—Docetaxel—lung cancer	0.000137	0.00044	CcSEcCtD
Dolasetron—Hypersensitivity—Paclitaxel—lung cancer	0.000137	0.00044	CcSEcCtD
Dolasetron—Oedema peripheral—Doxorubicin—lung cancer	0.000137	0.000438	CcSEcCtD
Dolasetron—Dysgeusia—Methotrexate—lung cancer	0.000136	0.000438	CcSEcCtD
Dolasetron—Asthenia—Etoposide—lung cancer	0.000136	0.000437	CcSEcCtD
Dolasetron—Fatigue—Docetaxel—lung cancer	0.000136	0.000437	CcSEcCtD
Dolasetron—Pain—Docetaxel—lung cancer	0.000135	0.000433	CcSEcCtD
Dolasetron—Constipation—Docetaxel—lung cancer	0.000135	0.000433	CcSEcCtD
Dolasetron—Pruritus—Etoposide—lung cancer	0.000134	0.000431	CcSEcCtD
Dolasetron—Visual impairment—Doxorubicin—lung cancer	0.000134	0.000429	CcSEcCtD
Dolasetron—Asthenia—Paclitaxel—lung cancer	0.000134	0.000429	CcSEcCtD
Dolasetron—Pruritus—Paclitaxel—lung cancer	0.000132	0.000423	CcSEcCtD
Dolasetron—Rash—Cisplatin—lung cancer	0.000131	0.000419	CcSEcCtD
Dolasetron—Dermatitis—Cisplatin—lung cancer	0.000131	0.000419	CcSEcCtD
Dolasetron—Feeling abnormal—Docetaxel—lung cancer	0.00013	0.000417	CcSEcCtD
Dolasetron—Diarrhoea—Etoposide—lung cancer	0.00013	0.000417	CcSEcCtD
Dolasetron—Ill-defined disorder—Methotrexate—lung cancer	0.000129	0.000415	CcSEcCtD
Dolasetron—Tinnitus—Doxorubicin—lung cancer	0.000129	0.000415	CcSEcCtD
Dolasetron—Gastrointestinal pain—Docetaxel—lung cancer	0.000129	0.000414	CcSEcCtD
Dolasetron—Anaemia—Methotrexate—lung cancer	0.000129	0.000413	CcSEcCtD
Dolasetron—Flushing—Doxorubicin—lung cancer	0.000129	0.000413	CcSEcCtD
Dolasetron—Diarrhoea—Paclitaxel—lung cancer	0.000127	0.000409	CcSEcCtD
Dolasetron—Malaise—Methotrexate—lung cancer	0.000126	0.000403	CcSEcCtD
Dolasetron—Dizziness—Etoposide—lung cancer	0.000126	0.000403	CcSEcCtD
Dolasetron—Vertigo—Methotrexate—lung cancer	0.000125	0.000402	CcSEcCtD
Dolasetron—Abdominal pain—Docetaxel—lung cancer	0.000125	0.0004	CcSEcCtD
Dolasetron—Body temperature increased—Docetaxel—lung cancer	0.000125	0.0004	CcSEcCtD
Dolasetron—Chills—Doxorubicin—lung cancer	0.000124	0.000399	CcSEcCtD
Dolasetron—Arrhythmia—Doxorubicin—lung cancer	0.000124	0.000397	CcSEcCtD
Dolasetron—Dizziness—Paclitaxel—lung cancer	0.000123	0.000395	CcSEcCtD
Dolasetron—Cough—Methotrexate—lung cancer	0.000122	0.00039	CcSEcCtD
Dolasetron—Convulsion—Methotrexate—lung cancer	0.000121	0.000388	CcSEcCtD
Dolasetron—Rash—Etoposide—lung cancer	0.00012	0.000384	CcSEcCtD
Dolasetron—Dermatitis—Etoposide—lung cancer	0.00012	0.000384	CcSEcCtD
Dolasetron—Headache—Etoposide—lung cancer	0.000119	0.000382	CcSEcCtD
Dolasetron—Flatulence—Doxorubicin—lung cancer	0.000119	0.000382	CcSEcCtD
Dolasetron—Arthralgia—Methotrexate—lung cancer	0.000119	0.000381	CcSEcCtD
Dolasetron—Chest pain—Methotrexate—lung cancer	0.000119	0.000381	CcSEcCtD
Dolasetron—Myalgia—Methotrexate—lung cancer	0.000119	0.000381	CcSEcCtD
Dolasetron—Dysgeusia—Doxorubicin—lung cancer	0.000118	0.000379	CcSEcCtD
Dolasetron—Rash—Paclitaxel—lung cancer	0.000117	0.000377	CcSEcCtD
Dolasetron—Dermatitis—Paclitaxel—lung cancer	0.000117	0.000376	CcSEcCtD
Dolasetron—Discomfort—Methotrexate—lung cancer	0.000117	0.000376	CcSEcCtD
Dolasetron—Headache—Paclitaxel—lung cancer	0.000117	0.000374	CcSEcCtD
Dolasetron—Hypersensitivity—Docetaxel—lung cancer	0.000116	0.000373	CcSEcCtD
Dolasetron—CYP3A4—Metapathway biotransformation—CYP2A7—lung cancer	0.000115	0.00156	CbGpPWpGaD
Dolasetron—Confusional state—Methotrexate—lung cancer	0.000115	0.000368	CcSEcCtD
Dolasetron—Anaphylactic shock—Methotrexate—lung cancer	0.000114	0.000365	CcSEcCtD
Dolasetron—Asthenia—Docetaxel—lung cancer	0.000113	0.000363	CcSEcCtD
Dolasetron—HTR3A—Transmembrane transport of small molecules—ABCB1—lung cancer	0.000113	0.00153	CbGpPWpGaD
Dolasetron—Ill-defined disorder—Doxorubicin—lung cancer	0.000112	0.000359	CcSEcCtD
Dolasetron—Pruritus—Docetaxel—lung cancer	0.000112	0.000358	CcSEcCtD
Dolasetron—Anaemia—Doxorubicin—lung cancer	0.000112	0.000358	CcSEcCtD
Dolasetron—Thrombocytopenia—Methotrexate—lung cancer	0.000111	0.000357	CcSEcCtD
Dolasetron—Agitation—Doxorubicin—lung cancer	0.000111	0.000356	CcSEcCtD
Dolasetron—Hyperhidrosis—Methotrexate—lung cancer	0.00011	0.000353	CcSEcCtD
Dolasetron—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—lung cancer	0.000109	0.00148	CbGpPWpGaD
Dolasetron—Malaise—Doxorubicin—lung cancer	0.000109	0.000349	CcSEcCtD
Dolasetron—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—lung cancer	0.000108	0.00147	CbGpPWpGaD
Dolasetron—Vertigo—Doxorubicin—lung cancer	0.000108	0.000348	CcSEcCtD
Dolasetron—Anorexia—Methotrexate—lung cancer	0.000108	0.000348	CcSEcCtD
Dolasetron—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—lung cancer	0.000108	0.00147	CbGpPWpGaD
Dolasetron—Syncope—Doxorubicin—lung cancer	0.000108	0.000347	CcSEcCtD
Dolasetron—Diarrhoea—Docetaxel—lung cancer	0.000108	0.000347	CcSEcCtD
Dolasetron—CYP2D6—Biological oxidations—HPGDS—lung cancer	0.000108	0.00146	CbGpPWpGaD
Dolasetron—CYP2C9—Biological oxidations—HPGDS—lung cancer	0.000107	0.00145	CbGpPWpGaD
Dolasetron—Palpitations—Doxorubicin—lung cancer	0.000107	0.000342	CcSEcCtD
Dolasetron—Hypotension—Methotrexate—lung cancer	0.000106	0.000341	CcSEcCtD
Dolasetron—Loss of consciousness—Doxorubicin—lung cancer	0.000106	0.00034	CcSEcCtD
Dolasetron—Cough—Doxorubicin—lung cancer	0.000105	0.000338	CcSEcCtD
Dolasetron—CYP2D6—Biological oxidations—GSTT1—lung cancer	0.000105	0.00142	CbGpPWpGaD
Dolasetron—Convulsion—Doxorubicin—lung cancer	0.000105	0.000336	CcSEcCtD
Dolasetron—Dizziness—Docetaxel—lung cancer	0.000104	0.000335	CcSEcCtD
Dolasetron—Hypertension—Doxorubicin—lung cancer	0.000104	0.000334	CcSEcCtD
Dolasetron—CYP3A4—Biological oxidations—GSTA3—lung cancer	0.000104	0.00141	CbGpPWpGaD
Dolasetron—CYP2C9—Biological oxidations—GSTT1—lung cancer	0.000104	0.00141	CbGpPWpGaD
Dolasetron—Musculoskeletal discomfort—Methotrexate—lung cancer	0.000104	0.000333	CcSEcCtD
Dolasetron—CYP2D6—Biological oxidations—CYP2A6—lung cancer	0.000103	0.0014	CbGpPWpGaD
Dolasetron—CYP2D6—Biological oxidations—GCLC—lung cancer	0.000103	0.0014	CbGpPWpGaD
Dolasetron—Arthralgia—Doxorubicin—lung cancer	0.000103	0.00033	CcSEcCtD
Dolasetron—Chest pain—Doxorubicin—lung cancer	0.000103	0.00033	CcSEcCtD
Dolasetron—Myalgia—Doxorubicin—lung cancer	0.000103	0.00033	CcSEcCtD
Dolasetron—CYP2C9—Biological oxidations—CYP2A6—lung cancer	0.000103	0.00139	CbGpPWpGaD
Dolasetron—CYP2C9—Biological oxidations—GCLC—lung cancer	0.000103	0.00139	CbGpPWpGaD
Dolasetron—Anxiety—Doxorubicin—lung cancer	0.000102	0.000329	CcSEcCtD
Dolasetron—CYP3A4—Metapathway biotransformation—GSTA3—lung cancer	0.000102	0.00139	CbGpPWpGaD
Dolasetron—Paraesthesia—Methotrexate—lung cancer	0.000102	0.000328	CcSEcCtD
Dolasetron—Discomfort—Doxorubicin—lung cancer	0.000101	0.000326	CcSEcCtD
Dolasetron—Dyspnoea—Methotrexate—lung cancer	0.000101	0.000325	CcSEcCtD
Dolasetron—Somnolence—Methotrexate—lung cancer	0.000101	0.000325	CcSEcCtD
Dolasetron—Dry mouth—Doxorubicin—lung cancer	0.0001	0.000323	CcSEcCtD
Dolasetron—Dyspepsia—Methotrexate—lung cancer	0.0001	0.000321	CcSEcCtD
Dolasetron—CYP2C9—Arachidonic acid metabolism—PTGS2—lung cancer	0.0001	0.00136	CbGpPWpGaD
Dolasetron—Rash—Docetaxel—lung cancer	9.95e-05	0.000319	CcSEcCtD
Dolasetron—Dermatitis—Docetaxel—lung cancer	9.94e-05	0.000319	CcSEcCtD
Dolasetron—HTR3A—SIDS Susceptibility Pathways—IL6—lung cancer	9.94e-05	0.00135	CbGpPWpGaD
Dolasetron—Confusional state—Doxorubicin—lung cancer	9.93e-05	0.000319	CcSEcCtD
Dolasetron—Decreased appetite—Methotrexate—lung cancer	9.89e-05	0.000317	CcSEcCtD
Dolasetron—Headache—Docetaxel—lung cancer	9.88e-05	0.000317	CcSEcCtD
Dolasetron—Oedema—Doxorubicin—lung cancer	9.85e-05	0.000316	CcSEcCtD
Dolasetron—Anaphylactic shock—Doxorubicin—lung cancer	9.85e-05	0.000316	CcSEcCtD
Dolasetron—Fatigue—Methotrexate—lung cancer	9.8e-05	0.000315	CcSEcCtD
Dolasetron—Pain—Methotrexate—lung cancer	9.73e-05	0.000312	CcSEcCtD
Dolasetron—Shock—Doxorubicin—lung cancer	9.69e-05	0.000311	CcSEcCtD
Dolasetron—Thrombocytopenia—Doxorubicin—lung cancer	9.64e-05	0.00031	CcSEcCtD
Dolasetron—Tachycardia—Doxorubicin—lung cancer	9.61e-05	0.000309	CcSEcCtD
Dolasetron—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—lung cancer	9.59e-05	0.0013	CbGpPWpGaD
Dolasetron—Hyperhidrosis—Doxorubicin—lung cancer	9.52e-05	0.000306	CcSEcCtD
Dolasetron—CYP3A4—Biological oxidations—GSTA4—lung cancer	9.49e-05	0.00129	CbGpPWpGaD
Dolasetron—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—lung cancer	9.47e-05	0.00128	CbGpPWpGaD
Dolasetron—Anorexia—Doxorubicin—lung cancer	9.39e-05	0.000301	CcSEcCtD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—PLBD1—lung cancer	9.37e-05	0.00127	CbGpPWpGaD
Dolasetron—Feeling abnormal—Methotrexate—lung cancer	9.37e-05	0.000301	CcSEcCtD
Dolasetron—CYP3A4—Metapathway biotransformation—GSTA4—lung cancer	9.36e-05	0.00127	CbGpPWpGaD
Dolasetron—Gastrointestinal pain—Methotrexate—lung cancer	9.3e-05	0.000299	CcSEcCtD
Dolasetron—CYP3A4—Biological oxidations—GSTA2—lung cancer	9.25e-05	0.00125	CbGpPWpGaD
Dolasetron—Hypotension—Doxorubicin—lung cancer	9.2e-05	0.000295	CcSEcCtD
Dolasetron—Urticaria—Methotrexate—lung cancer	9.03e-05	0.00029	CcSEcCtD
Dolasetron—Body temperature increased—Methotrexate—lung cancer	8.99e-05	0.000289	CcSEcCtD
Dolasetron—Abdominal pain—Methotrexate—lung cancer	8.99e-05	0.000289	CcSEcCtD
Dolasetron—Musculoskeletal discomfort—Doxorubicin—lung cancer	8.97e-05	0.000288	CcSEcCtD
Dolasetron—CYP3A4—Biological oxidations—GSTA1—lung cancer	8.92e-05	0.00121	CbGpPWpGaD
Dolasetron—HTR3A—Transmembrane transport of small molecules—APOA1—lung cancer	8.89e-05	0.0012	CbGpPWpGaD
Dolasetron—CYP2D6—Phase 1 - Functionalization of compounds—POMC—lung cancer	8.87e-05	0.0012	CbGpPWpGaD
Dolasetron—Paraesthesia—Doxorubicin—lung cancer	8.84e-05	0.000284	CcSEcCtD
Dolasetron—CYP2D6—Biological oxidations—CYP2E1—lung cancer	8.79e-05	0.00119	CbGpPWpGaD
Dolasetron—CYP2C9—Phase 1 - Functionalization of compounds—POMC—lung cancer	8.79e-05	0.00119	CbGpPWpGaD
Dolasetron—Dyspnoea—Doxorubicin—lung cancer	8.78e-05	0.000282	CcSEcCtD
Dolasetron—Somnolence—Doxorubicin—lung cancer	8.75e-05	0.000281	CcSEcCtD
Dolasetron—CYP2C9—Biological oxidations—CYP2E1—lung cancer	8.72e-05	0.00118	CbGpPWpGaD
Dolasetron—CYP2D6—Metapathway biotransformation—CYP2E1—lung cancer	8.67e-05	0.00118	CbGpPWpGaD
Dolasetron—Dyspepsia—Doxorubicin—lung cancer	8.67e-05	0.000278	CcSEcCtD
Dolasetron—CYP2C9—Metapathway biotransformation—CYP2E1—lung cancer	8.6e-05	0.00117	CbGpPWpGaD
Dolasetron—Decreased appetite—Doxorubicin—lung cancer	8.56e-05	0.000275	CcSEcCtD
Dolasetron—Fatigue—Doxorubicin—lung cancer	8.49e-05	0.000273	CcSEcCtD
Dolasetron—CYP3A4—Metapathway biotransformation—AKR1C1—lung cancer	8.43e-05	0.00114	CbGpPWpGaD
Dolasetron—Pain—Doxorubicin—lung cancer	8.42e-05	0.00027	CcSEcCtD
Dolasetron—Constipation—Doxorubicin—lung cancer	8.42e-05	0.00027	CcSEcCtD
Dolasetron—Hypersensitivity—Methotrexate—lung cancer	8.38e-05	0.000269	CcSEcCtD
Dolasetron—CYP3A4—Biological oxidations—UGT1A1—lung cancer	8.29e-05	0.00112	CbGpPWpGaD
Dolasetron—CYP3A4—Metapathway biotransformation—UGT1A1—lung cancer	8.18e-05	0.00111	CbGpPWpGaD
Dolasetron—Asthenia—Methotrexate—lung cancer	8.16e-05	0.000262	CcSEcCtD
Dolasetron—Feeling abnormal—Doxorubicin—lung cancer	8.11e-05	0.000261	CcSEcCtD
Dolasetron—Gastrointestinal pain—Doxorubicin—lung cancer	8.05e-05	0.000259	CcSEcCtD
Dolasetron—Pruritus—Methotrexate—lung cancer	8.05e-05	0.000258	CcSEcCtD
Dolasetron—Urticaria—Doxorubicin—lung cancer	7.82e-05	0.000251	CcSEcCtD
Dolasetron—Body temperature increased—Doxorubicin—lung cancer	7.78e-05	0.00025	CcSEcCtD
Dolasetron—Abdominal pain—Doxorubicin—lung cancer	7.78e-05	0.00025	CcSEcCtD
Dolasetron—Diarrhoea—Methotrexate—lung cancer	7.78e-05	0.00025	CcSEcCtD
Dolasetron—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—lung cancer	7.78e-05	0.00105	CbGpPWpGaD
Dolasetron—HTR3A—Transmembrane transport of small molecules—CREBBP—lung cancer	7.52e-05	0.00102	CbGpPWpGaD
Dolasetron—Dizziness—Methotrexate—lung cancer	7.52e-05	0.000241	CcSEcCtD
Dolasetron—CYP3A4—Tryptophan metabolism—MDM2—lung cancer	7.32e-05	0.000992	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—MTMR3—lung cancer	7.29e-05	0.000988	CbGpPWpGaD
Dolasetron—Hypersensitivity—Doxorubicin—lung cancer	7.26e-05	0.000233	CcSEcCtD
Dolasetron—CYP2D6—Biological oxidations—GSTP1—lung cancer	7.25e-05	0.000983	CbGpPWpGaD
Dolasetron—CYP2C9—Biological oxidations—GSTP1—lung cancer	7.19e-05	0.000975	CbGpPWpGaD
Dolasetron—Rash—Methotrexate—lung cancer	7.17e-05	0.00023	CcSEcCtD
Dolasetron—Dermatitis—Methotrexate—lung cancer	7.16e-05	0.00023	CcSEcCtD
Dolasetron—CYP2D6—Metapathway biotransformation—GSTP1—lung cancer	7.15e-05	0.00097	CbGpPWpGaD
Dolasetron—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—lung cancer	7.15e-05	0.00097	CbGpPWpGaD
Dolasetron—Headache—Methotrexate—lung cancer	7.12e-05	0.000229	CcSEcCtD
Dolasetron—CYP2C9—Metapathway biotransformation—GSTP1—lung cancer	7.09e-05	0.000961	CbGpPWpGaD
Dolasetron—Asthenia—Doxorubicin—lung cancer	7.07e-05	0.000227	CcSEcCtD
Dolasetron—CYP3A4—Biological oxidations—HPGDS—lung cancer	7.05e-05	0.000956	CbGpPWpGaD
Dolasetron—HTR3A—Transmembrane transport of small molecules—ALB—lung cancer	7.04e-05	0.000955	CbGpPWpGaD
Dolasetron—Pruritus—Doxorubicin—lung cancer	6.97e-05	0.000224	CcSEcCtD
Dolasetron—CYP3A4—Biological oxidations—GSTT1—lung cancer	6.84e-05	0.000927	CbGpPWpGaD
Dolasetron—CYP3A4—Biological oxidations—CYP2A6—lung cancer	6.76e-05	0.000917	CbGpPWpGaD
Dolasetron—CYP3A4—Biological oxidations—GCLC—lung cancer	6.76e-05	0.000917	CbGpPWpGaD
Dolasetron—Diarrhoea—Doxorubicin—lung cancer	6.74e-05	0.000216	CcSEcCtD
Dolasetron—CYP2D6—Biological oxidations—GSTM1—lung cancer	6.66e-05	0.000904	CbGpPWpGaD
Dolasetron—CYP2C9—Biological oxidations—GSTM1—lung cancer	6.61e-05	0.000896	CbGpPWpGaD
Dolasetron—CYP2D6—Metapathway biotransformation—GSTM1—lung cancer	6.57e-05	0.000891	CbGpPWpGaD
Dolasetron—CYP2C9—Metapathway biotransformation—GSTM1—lung cancer	6.52e-05	0.000883	CbGpPWpGaD
Dolasetron—Dizziness—Doxorubicin—lung cancer	6.51e-05	0.000209	CcSEcCtD
Dolasetron—HTR3A—Transmembrane transport of small molecules—RAF1—lung cancer	6.37e-05	0.000863	CbGpPWpGaD
Dolasetron—CYP2D6—Biological oxidations—CYP1A1—lung cancer	6.32e-05	0.000857	CbGpPWpGaD
Dolasetron—CYP2C9—Biological oxidations—CYP1A1—lung cancer	6.26e-05	0.000849	CbGpPWpGaD
Dolasetron—CYP2D6—Metapathway biotransformation—CYP1A1—lung cancer	6.23e-05	0.000845	CbGpPWpGaD
Dolasetron—Rash—Doxorubicin—lung cancer	6.21e-05	0.000199	CcSEcCtD
Dolasetron—Dermatitis—Doxorubicin—lung cancer	6.2e-05	0.000199	CcSEcCtD
Dolasetron—CYP2C9—Metapathway biotransformation—CYP1A1—lung cancer	6.18e-05	0.000837	CbGpPWpGaD
Dolasetron—Headache—Doxorubicin—lung cancer	6.17e-05	0.000198	CcSEcCtD
Dolasetron—CYP3A4—Phase 1 - Functionalization of compounds—POMC—lung cancer	5.8e-05	0.000786	CbGpPWpGaD
Dolasetron—CYP3A4—Biological oxidations—CYP2E1—lung cancer	5.75e-05	0.000779	CbGpPWpGaD
Dolasetron—CYP3A4—Metapathway biotransformation—CYP2E1—lung cancer	5.67e-05	0.000769	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—COL4A3BP—lung cancer	5.56e-05	0.000753	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—AZIN2—lung cancer	5.56e-05	0.000753	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—AZIN2—lung cancer	5.51e-05	0.000747	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—COL4A3BP—lung cancer	5.51e-05	0.000747	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—ABCC3—lung cancer	5.14e-05	0.000696	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C1—lung cancer	4.97e-05	0.000674	CbGpPWpGaD
Dolasetron—CYP3A4—Biological oxidations—GSTP1—lung cancer	4.74e-05	0.000643	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—ATP5H—lung cancer	4.73e-05	0.000641	CbGpPWpGaD
Dolasetron—CYP2D6—Biological oxidations—POMC—lung cancer	4.71e-05	0.000639	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—ATP5H—lung cancer	4.68e-05	0.000635	CbGpPWpGaD
Dolasetron—CYP3A4—Metapathway biotransformation—GSTP1—lung cancer	4.68e-05	0.000634	CbGpPWpGaD
Dolasetron—CYP2C9—Biological oxidations—POMC—lung cancer	4.67e-05	0.000633	CbGpPWpGaD
Dolasetron—CYP3A4—Biological oxidations—GSTM1—lung cancer	4.36e-05	0.000591	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—NCOA3—lung cancer	4.3e-05	0.000584	CbGpPWpGaD
Dolasetron—CYP3A4—Metapathway biotransformation—GSTM1—lung cancer	4.3e-05	0.000583	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—PLBD1—lung cancer	4.21e-05	0.000571	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—PLBD1—lung cancer	4.18e-05	0.000566	CbGpPWpGaD
Dolasetron—CYP3A4—Biological oxidations—CYP1A1—lung cancer	4.13e-05	0.00056	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—lung cancer	4.11e-05	0.000557	CbGpPWpGaD
Dolasetron—CYP3A4—Metapathway biotransformation—CYP1A1—lung cancer	4.07e-05	0.000552	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—HSD17B10—lung cancer	3.85e-05	0.000522	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—HSD17B10—lung cancer	3.82e-05	0.000518	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—AZIN2—lung cancer	3.63e-05	0.000493	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—COL4A3BP—lung cancer	3.63e-05	0.000493	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—CKB—lung cancer	3.58e-05	0.000486	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—CKB—lung cancer	3.55e-05	0.000481	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—GSTM2—lung cancer	3.37e-05	0.000456	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—CNDP2—lung cancer	3.37e-05	0.000456	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—CNDP2—lung cancer	3.34e-05	0.000453	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—GSTM2—lung cancer	3.34e-05	0.000453	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—MTMR3—lung cancer	3.28e-05	0.000444	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—MTMR3—lung cancer	3.25e-05	0.00044	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—PGAM1—lung cancer	3.19e-05	0.000433	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—PGAM1—lung cancer	3.16e-05	0.000429	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—ATP5H—lung cancer	3.09e-05	0.000419	CbGpPWpGaD
Dolasetron—CYP3A4—Biological oxidations—POMC—lung cancer	3.08e-05	0.000418	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—CYP2A7—lung cancer	3.04e-05	0.000413	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—CYP2A7—lung cancer	3.02e-05	0.000409	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—SDC4—lung cancer	2.98e-05	0.000404	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—SDC4—lung cancer	2.95e-05	0.0004	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—PLBD1—lung cancer	2.75e-05	0.000373	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—RRM1—lung cancer	2.71e-05	0.000368	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—GSTA3—lung cancer	2.71e-05	0.000368	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—RRM1—lung cancer	2.69e-05	0.000365	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—GSTA3—lung cancer	2.69e-05	0.000365	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—B4GALT5—lung cancer	2.55e-05	0.000346	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—B4GALT5—lung cancer	2.53e-05	0.000343	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—HSD17B10—lung cancer	2.52e-05	0.000341	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—GSTA4—lung cancer	2.48e-05	0.000337	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—GSTA4—lung cancer	2.46e-05	0.000334	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—GSTA2—lung cancer	2.42e-05	0.000328	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	2.4e-05	0.000326	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—GSTA2—lung cancer	2.4e-05	0.000325	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—CKB—lung cancer	2.34e-05	0.000317	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—GSTA1—lung cancer	2.33e-05	0.000316	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—GSTA1—lung cancer	2.31e-05	0.000314	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—ABCC3—lung cancer	2.31e-05	0.000313	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—ABCC3—lung cancer	2.29e-05	0.00031	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—AKR1C1—lung cancer	2.23e-05	0.000303	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—AKR1C1—lung cancer	2.22e-05	0.0003	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—GSTM2—lung cancer	2.2e-05	0.000298	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—CNDP2—lung cancer	2.2e-05	0.000298	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—UGT1A1—lung cancer	2.17e-05	0.000294	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—UGT1A1—lung cancer	2.15e-05	0.000292	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—MTMR3—lung cancer	2.14e-05	0.00029	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—GNG11—lung cancer	2.09e-05	0.000284	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—PGAM1—lung cancer	2.09e-05	0.000283	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—GNG11—lung cancer	2.07e-05	0.000281	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—lung cancer	2.06e-05	0.00028	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—ALDOA—lung cancer	1.99e-05	0.00027	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—CYP2A7—lung cancer	1.99e-05	0.00027	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—ALDOA—lung cancer	1.97e-05	0.000268	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—SDC4—lung cancer	1.95e-05	0.000264	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—NCOA3—lung cancer	1.93e-05	0.000262	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—NCOA3—lung cancer	1.92e-05	0.00026	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	1.88e-05	0.000255	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—ADCY1—lung cancer	1.88e-05	0.000255	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—ABCG2—lung cancer	1.88e-05	0.000255	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—ABCG2—lung cancer	1.86e-05	0.000253	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—ADCY1—lung cancer	1.86e-05	0.000253	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—ENO2—lung cancer	1.84e-05	0.00025	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—HPGDS—lung cancer	1.84e-05	0.00025	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—PPP2R1B—lung cancer	1.83e-05	0.000249	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—HPGDS—lung cancer	1.83e-05	0.000248	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—ENO2—lung cancer	1.83e-05	0.000248	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—PPP2R1B—lung cancer	1.82e-05	0.000246	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—POMC—lung cancer	1.79e-05	0.000243	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—GSTT1—lung cancer	1.79e-05	0.000243	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—GSTA3—lung cancer	1.77e-05	0.000241	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—RRM1—lung cancer	1.77e-05	0.000241	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—GSTT1—lung cancer	1.77e-05	0.00024	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—CYP2A6—lung cancer	1.77e-05	0.00024	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—GCLC—lung cancer	1.77e-05	0.00024	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—GCLC—lung cancer	1.75e-05	0.000238	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—CYP2A6—lung cancer	1.75e-05	0.000238	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	1.75e-05	0.000237	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—ENO1—lung cancer	1.68e-05	0.000227	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—B4GALT5—lung cancer	1.67e-05	0.000226	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—ENO1—lung cancer	1.66e-05	0.000225	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	1.66e-05	0.000225	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—ALB—lung cancer	1.63e-05	0.000222	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—GSTA4—lung cancer	1.62e-05	0.00022	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—GSTA2—lung cancer	1.58e-05	0.000214	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—GSTA1—lung cancer	1.53e-05	0.000207	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—ABCC3—lung cancer	1.51e-05	0.000205	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—CYP2E1—lung cancer	1.5e-05	0.000204	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—CYP2E1—lung cancer	1.49e-05	0.000202	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—NQO1—lung cancer	1.49e-05	0.000202	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—NQO1—lung cancer	1.47e-05	0.0002	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—AKR1C1—lung cancer	1.46e-05	0.000198	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	1.44e-05	0.000196	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	1.43e-05	0.000194	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—UGT1A1—lung cancer	1.42e-05	0.000192	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—GNG11—lung cancer	1.37e-05	0.000185	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—STK11—lung cancer	1.34e-05	0.000182	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—STK11—lung cancer	1.33e-05	0.00018	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—ALDOA—lung cancer	1.3e-05	0.000177	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—NCOA3—lung cancer	1.26e-05	0.000171	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—lung cancer	1.25e-05	0.000169	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—GSTP1—lung cancer	1.24e-05	0.000168	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—ADCY1—lung cancer	1.23e-05	0.000167	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—ABCG2—lung cancer	1.23e-05	0.000167	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—GSTP1—lung cancer	1.23e-05	0.000167	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—CAT—lung cancer	1.21e-05	0.000164	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—ENO2—lung cancer	1.21e-05	0.000164	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—HPGDS—lung cancer	1.21e-05	0.000164	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—PPP2R1B—lung cancer	1.2e-05	0.000162	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—CAT—lung cancer	1.2e-05	0.000162	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.19e-05	0.000161	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—ABCB1—lung cancer	1.17e-05	0.000159	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—GSTT1—lung cancer	1.17e-05	0.000159	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—ABCB1—lung cancer	1.16e-05	0.000158	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—CYP2A6—lung cancer	1.16e-05	0.000157	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—GCLC—lung cancer	1.16e-05	0.000157	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—TYMS—lung cancer	1.15e-05	0.000156	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—TYMS—lung cancer	1.14e-05	0.000155	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—GSTM1—lung cancer	1.14e-05	0.000155	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—GSTM1—lung cancer	1.13e-05	0.000153	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—ENO1—lung cancer	1.1e-05	0.000149	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—CYP1A1—lung cancer	1.08e-05	0.000146	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—ERCC2—lung cancer	1.07e-05	0.000145	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—CYP1A1—lung cancer	1.07e-05	0.000145	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—ERCC2—lung cancer	1.06e-05	0.000144	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—CYP2E1—lung cancer	9.83e-06	0.000133	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—NQO1—lung cancer	9.72e-06	0.000132	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—APOA1—lung cancer	9.27e-06	0.000126	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—APOA1—lung cancer	9.19e-06	0.000125	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	8.8e-06	0.000119	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—STK11—lung cancer	8.76e-06	0.000119	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—PIK3CG—lung cancer	8.46e-06	0.000115	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—PIK3CG—lung cancer	8.39e-06	0.000114	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—GSTP1—lung cancer	8.11e-06	0.00011	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—POMC—lung cancer	8.06e-06	0.000109	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—POMC—lung cancer	7.99e-06	0.000108	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—CAT—lung cancer	7.89e-06	0.000107	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—CREBBP—lung cancer	7.85e-06	0.000106	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—CREBBP—lung cancer	7.78e-06	0.000105	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—ABCB1—lung cancer	7.68e-06	0.000104	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—TYMS—lung cancer	7.54e-06	0.000102	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—GSTM1—lung cancer	7.45e-06	0.000101	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—PIK3CD—lung cancer	7.44e-06	0.000101	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—PIK3CD—lung cancer	7.38e-06	0.0001	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—ALB—lung cancer	7.34e-06	9.96e-05	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—ALB—lung cancer	7.28e-06	9.87e-05	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—CYP1A1—lung cancer	7.06e-06	9.58e-05	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—ERCC2—lung cancer	7.01e-06	9.5e-05	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—PIK3CB—lung cancer	6.48e-06	8.79e-05	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—PIK3CB—lung cancer	6.43e-06	8.72e-05	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—PTGS2—lung cancer	6.43e-06	8.71e-05	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—PTGS2—lung cancer	6.37e-06	8.64e-05	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—APOA1—lung cancer	6.06e-06	8.22e-05	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—PTEN—lung cancer	5.6e-06	7.6e-05	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—PTEN—lung cancer	5.55e-06	7.53e-05	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—PIK3CG—lung cancer	5.53e-06	7.5e-05	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—EP300—lung cancer	5.34e-06	7.25e-05	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—EP300—lung cancer	5.3e-06	7.18e-05	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—POMC—lung cancer	5.27e-06	7.14e-05	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—CREBBP—lung cancer	5.13e-06	6.96e-05	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—PIK3CD—lung cancer	4.86e-06	6.59e-05	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—ALB—lung cancer	4.8e-06	6.51e-05	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—PIK3CB—lung cancer	4.24e-06	5.75e-05	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—PTGS2—lung cancer	4.2e-06	5.7e-05	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—PIK3CA—lung cancer	3.95e-06	5.36e-05	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—PIK3CA—lung cancer	3.92e-06	5.31e-05	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—PTEN—lung cancer	3.66e-06	4.97e-05	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—EP300—lung cancer	3.49e-06	4.74e-05	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—AKT1—lung cancer	3.23e-06	4.38e-05	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—AKT1—lung cancer	3.2e-06	4.34e-05	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—PIK3CA—lung cancer	2.58e-06	3.5e-05	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—AKT1—lung cancer	2.11e-06	2.86e-05	CbGpPWpGaD
